About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

GSK Type 1 Diabetes Drug Does Not Make It in Phase III Clinical Trials

by Savitha C Muppala on March 13, 2011 at 2:37 PM
Font : A-A+

 GSK Type 1 Diabetes Drug Does Not Make It in Phase III Clinical Trials

A Type 1 diabetes drug developed by London-based GlaxoSmithKline and Cambridge, Massachusetts-based Tolerx, was not successful in the phase III clinical trials.

Explaining their commitment to the clinical development of type 1 diabetes drug, Jackie Parkin, GSK's medicines development leader, said, "Clearly these are disappointing data, but we are committed to working with Tolerx to better understand the results of this study and determine the way forward."

Advertisement


Source: Medindia

Advertisement
Advertisement
Advertisement

Recommended Reading

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

GSK Type 1 Diabetes Drug Does Not Make It in Phase III Clinical Trials Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests